Interferon-gamma release assays (IGRAs), such as the QuantiFERON®-TB Gold Plus (QFT; Qiagen, Hilden, Germany), are widely used in tuberculosis (TB) screening, especially in children requiring immunosuppressive therapy. Here, IFNG is linked to tuberculosis.